Global Brucellosis Vaccines Market Research Report 2023

Global Brucellosis Vaccines Market Research Report 2023

Table of Contents
1 Brucellosis Vaccines Market Overview
1.1 Product Overview and Scope of Brucellosis Vaccines
1.2 Brucellosis Vaccines Segment by Type
1.2.1 Global Brucellosis Vaccines Market Value Comparison by Type (2023-2029)
1.2.2 S19 Vaccine
1.2.3 RB51 Vaccine Strain
1.3 Brucellosis Vaccines Segment by Application
1.3.1 Global Brucellosis Vaccines Market Value by Application: (2023-2029)
1.3.2 Cattle
1.3.3 Sheep
1.3.4 Others
1.4 Global Brucellosis Vaccines Market Size Estimates and Forecasts
1.4.1 Global Brucellosis Vaccines Revenue 2018-2029
1.4.2 Global Brucellosis Vaccines Sales 2018-2029
1.4.3 Global Brucellosis Vaccines Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Brucellosis Vaccines Market Competition by Manufacturers
2.1 Global Brucellosis Vaccines Sales Market Share by Manufacturers (2018-2023)
2.2 Global Brucellosis Vaccines Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Brucellosis Vaccines Average Price by Manufacturers (2018-2023)
2.4 Global Brucellosis Vaccines Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Brucellosis Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Brucellosis Vaccines, Product Type & Application
2.7 Brucellosis Vaccines Market Competitive Situation and Trends
2.7.1 Brucellosis Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Brucellosis Vaccines Players Market Share by Revenue
2.7.3 Global Brucellosis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Brucellosis Vaccines Retrospective Market Scenario by Region
3.1 Global Brucellosis Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Brucellosis Vaccines Global Brucellosis Vaccines Sales by Region: 2018-2029
3.2.1 Global Brucellosis Vaccines Sales by Region: 2018-2023
3.2.2 Global Brucellosis Vaccines Sales by Region: 2024-2029
3.3 Global Brucellosis Vaccines Global Brucellosis Vaccines Revenue by Region: 2018-2029
3.3.1 Global Brucellosis Vaccines Revenue by Region: 2018-2023
3.3.2 Global Brucellosis Vaccines Revenue by Region: 2024-2029
3.4 North America Brucellosis Vaccines Market Facts & Figures by Country
3.4.1 North America Brucellosis Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Brucellosis Vaccines Sales by Country (2018-2029)
3.4.3 North America Brucellosis Vaccines Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Brucellosis Vaccines Market Facts & Figures by Country
3.5.1 Europe Brucellosis Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Brucellosis Vaccines Sales by Country (2018-2029)
3.5.3 Europe Brucellosis Vaccines Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Brucellosis Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Brucellosis Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Brucellosis Vaccines Sales by Country (2018-2029)
3.6.3 Asia Pacific Brucellosis Vaccines Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Brucellosis Vaccines Market Facts & Figures by Country
3.7.1 Latin America Brucellosis Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Brucellosis Vaccines Sales by Country (2018-2029)
3.7.3 Latin America Brucellosis Vaccines Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Brucellosis Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Brucellosis Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Brucellosis Vaccines Sales by Country (2018-2029)
3.8.3 Middle East and Africa Brucellosis Vaccines Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Brucellosis Vaccines Sales by Type (2018-2029)
4.1.1 Global Brucellosis Vaccines Sales by Type (2018-2023)
4.1.2 Global Brucellosis Vaccines Sales by Type (2024-2029)
4.1.3 Global Brucellosis Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Brucellosis Vaccines Revenue by Type (2018-2029)
4.2.1 Global Brucellosis Vaccines Revenue by Type (2018-2023)
4.2.2 Global Brucellosis Vaccines Revenue by Type (2024-2029)
4.2.3 Global Brucellosis Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Brucellosis Vaccines Price by Type (2018-2029)
5 Segment by Application
5.1 Global Brucellosis Vaccines Sales by Application (2018-2029)
5.1.1 Global Brucellosis Vaccines Sales by Application (2018-2023)
5.1.2 Global Brucellosis Vaccines Sales by Application (2024-2029)
5.1.3 Global Brucellosis Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Brucellosis Vaccines Revenue by Application (2018-2029)
5.2.1 Global Brucellosis Vaccines Revenue by Application (2018-2023)
5.2.2 Global Brucellosis Vaccines Revenue by Application (2024-2029)
5.2.3 Global Brucellosis Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Brucellosis Vaccines Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Jinyu
6.1.1 Jinyu Corporation Information
6.1.2 Jinyu Description and Business Overview
6.1.3 Jinyu Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Jinyu Brucellosis Vaccines Product Portfolio
6.1.5 Jinyu Recent Developments/Updates
6.2 Colorado Serum
6.2.1 Colorado Serum Corporation Information
6.2.2 Colorado Serum Description and Business Overview
6.2.3 Colorado Serum Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Colorado Serum Brucellosis Vaccines Product Portfolio
6.2.5 Colorado Serum Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Boehringer Ingelheim Brucellosis Vaccines Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Biogenesis-Bago
6.4.1 Biogenesis-Bago Corporation Information
6.4.2 Biogenesis-Bago Description and Business Overview
6.4.3 Biogenesis-Bago Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Biogenesis-Bago Brucellosis Vaccines Product Portfolio
6.4.5 Biogenesis-Bago Recent Developments/Updates
6.5 Vetal Company
6.5.1 Vetal Company Corporation Information
6.5.2 Vetal Company Description and Business Overview
6.5.3 Vetal Company Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Vetal Company Brucellosis Vaccines Product Portfolio
6.5.5 Vetal Company Recent Developments/Updates
6.6 CZ Veterinaria
6.6.1 CZ Veterinaria Corporation Information
6.6.2 CZ Veterinaria Description and Business Overview
6.6.3 CZ Veterinaria Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.6.4 CZ Veterinaria Brucellosis Vaccines Product Portfolio
6.6.5 CZ Veterinaria Recent Developments/Updates
6.7 SYVA Laboratorios
6.6.1 SYVA Laboratorios Corporation Information
6.6.2 SYVA Laboratorios Description and Business Overview
6.6.3 SYVA Laboratorios Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 SYVA Laboratorios Brucellosis Vaccines Product Portfolio
6.7.5 SYVA Laboratorios Recent Developments/Updates
6.8 Indian Immunologicals
6.8.1 Indian Immunologicals Corporation Information
6.8.2 Indian Immunologicals Description and Business Overview
6.8.3 Indian Immunologicals Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Indian Immunologicals Brucellosis Vaccines Product Portfolio
6.8.5 Indian Immunologicals Recent Developments/Updates
6.9 Qilu
6.9.1 Qilu Corporation Information
6.9.2 Qilu Description and Business Overview
6.9.3 Qilu Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Qilu Brucellosis Vaccines Product Portfolio
6.9.5 Qilu Recent Developments/Updates
6.10 Tecnovax
6.10.1 Tecnovax Corporation Information
6.10.2 Tecnovax Description and Business Overview
6.10.3 Tecnovax Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Tecnovax Brucellosis Vaccines Product Portfolio
6.10.5 Tecnovax Recent Developments/Updates
6.11 Hester Biosciences
6.11.1 Hester Biosciences Corporation Information
6.11.2 Hester Biosciences Brucellosis Vaccines Description and Business Overview
6.11.3 Hester Biosciences Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Hester Biosciences Brucellosis Vaccines Product Portfolio
6.11.5 Hester Biosciences Recent Developments/Updates
6.12 Zoetis
6.12.1 Zoetis Corporation Information
6.12.2 Zoetis Brucellosis Vaccines Description and Business Overview
6.12.3 Zoetis Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Zoetis Brucellosis Vaccines Product Portfolio
6.12.5 Zoetis Recent Developments/Updates
6.13 Onderstepoort Biological
6.13.1 Onderstepoort Biological Corporation Information
6.13.2 Onderstepoort Biological Brucellosis Vaccines Description and Business Overview
6.13.3 Onderstepoort Biological Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Onderstepoort Biological Brucellosis Vaccines Product Portfolio
6.13.5 Onderstepoort Biological Recent Developments/Updates
6.14 Instituto Rosenbusch
6.14.1 Instituto Rosenbusch Corporation Information
6.14.2 Instituto Rosenbusch Brucellosis Vaccines Description and Business Overview
6.14.3 Instituto Rosenbusch Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Instituto Rosenbusch Brucellosis Vaccines Product Portfolio
6.14.5 Instituto Rosenbusch Recent Developments/Updates
6.15 Ceva Sante Animale
6.15.1 Ceva Sante Animale Corporation Information
6.15.2 Ceva Sante Animale Brucellosis Vaccines Description and Business Overview
6.15.3 Ceva Sante Animale Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Ceva Sante Animale Brucellosis Vaccines Product Portfolio
6.15.5 Ceva Sante Animale Recent Developments/Updates
6.16 Calier & Biologicos Laverlam
6.16.1 Calier & Biologicos Laverlam Corporation Information
6.16.2 Calier & Biologicos Laverlam Brucellosis Vaccines Description and Business Overview
6.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Calier & Biologicos Laverlam Brucellosis Vaccines Product Portfolio
6.16.5 Calier & Biologicos Laverlam Recent Developments/Updates
6.17 Biovet
6.17.1 Biovet Corporation Information
6.17.2 Biovet Brucellosis Vaccines Description and Business Overview
6.17.3 Biovet Brucellosis Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Biovet Brucellosis Vaccines Product Portfolio
6.17.5 Biovet Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Brucellosis Vaccines Industry Chain Analysis
7.2 Brucellosis Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Brucellosis Vaccines Production Mode & Process
7.4 Brucellosis Vaccines Sales and Marketing
7.4.1 Brucellosis Vaccines Sales Channels
7.4.2 Brucellosis Vaccines Distributors
7.5 Brucellosis Vaccines Customers
8 Brucellosis Vaccines Market Dynamics
8.1 Brucellosis Vaccines Industry Trends
8.2 Brucellosis Vaccines Market Drivers
8.3 Brucellosis Vaccines Market Challenges
8.4 Brucellosis Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Brucellosis Vaccines Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Brucellosis Vaccines Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Brucellosis Vaccines Market Competitive Situation by Manufacturers in 2022
Table 4. Global Brucellosis Vaccines Sales (M Doses) of Key Manufacturers (2018-2023)
Table 5. Global Brucellosis Vaccines Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Brucellosis Vaccines Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Brucellosis Vaccines Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Brucellosis Vaccines Average Price (USD/K Doses) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Brucellosis Vaccines, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Brucellosis Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Brucellosis Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Brucellosis Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Brucellosis Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brucellosis Vaccines as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Brucellosis Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Brucellosis Vaccines Sales by Region (2018-2023) & (M Doses)
Table 18. Global Brucellosis Vaccines Sales Market Share by Region (2018-2023)
Table 19. Global Brucellosis Vaccines Sales by Region (2024-2029) & (M Doses)
Table 20. Global Brucellosis Vaccines Sales Market Share by Region (2024-2029)
Table 21. Global Brucellosis Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Brucellosis Vaccines Revenue Market Share by Region (2018-2023)
Table 23. Global Brucellosis Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Brucellosis Vaccines Revenue Market Share by Region (2024-2029)
Table 25. North America Brucellosis Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Brucellosis Vaccines Sales by Country (2018-2023) & (M Doses)
Table 27. North America Brucellosis Vaccines Sales by Country (2024-2029) & (M Doses)
Table 28. North America Brucellosis Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Brucellosis Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Brucellosis Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Brucellosis Vaccines Sales by Country (2018-2023) & (M Doses)
Table 32. Europe Brucellosis Vaccines Sales by Country (2024-2029) & (M Doses)
Table 33. Europe Brucellosis Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Brucellosis Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Brucellosis Vaccines Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Brucellosis Vaccines Sales by Region (2018-2023) & (M Doses)
Table 37. Asia Pacific Brucellosis Vaccines Sales by Region (2024-2029) & (M Doses)
Table 38. Asia Pacific Brucellosis Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Brucellosis Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Brucellosis Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Brucellosis Vaccines Sales by Country (2018-2023) & (M Doses)
Table 42. Latin America Brucellosis Vaccines Sales by Country (2024-2029) & (M Doses)
Table 43. Latin America Brucellosis Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Brucellosis Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Brucellosis Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Brucellosis Vaccines Sales by Country (2018-2023) & (M Doses)
Table 47. Middle East & Africa Brucellosis Vaccines Sales by Country (2024-2029) & (M Doses)
Table 48. Middle East & Africa Brucellosis Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Brucellosis Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Brucellosis Vaccines Sales (M Doses) by Type (2018-2023)
Table 51. Global Brucellosis Vaccines Sales (M Doses) by Type (2024-2029)
Table 52. Global Brucellosis Vaccines Sales Market Share by Type (2018-2023)
Table 53. Global Brucellosis Vaccines Sales Market Share by Type (2024-2029)
Table 54. Global Brucellosis Vaccines Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Brucellosis Vaccines Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Brucellosis Vaccines Revenue Market Share by Type (2018-2023)
Table 57. Global Brucellosis Vaccines Revenue Market Share by Type (2024-2029)
Table 58. Global Brucellosis Vaccines Price (USD/K Doses) by Type (2018-2023)
Table 59. Global Brucellosis Vaccines Price (USD/K Doses) by Type (2024-2029)
Table 60. Global Brucellosis Vaccines Sales (M Doses) by Application (2018-2023)
Table 61. Global Brucellosis Vaccines Sales (M Doses) by Application (2024-2029)
Table 62. Global Brucellosis Vaccines Sales Market Share by Application (2018-2023)
Table 63. Global Brucellosis Vaccines Sales Market Share by Application (2024-2029)
Table 64. Global Brucellosis Vaccines Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Brucellosis Vaccines Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Brucellosis Vaccines Revenue Market Share by Application (2018-2023)
Table 67. Global Brucellosis Vaccines Revenue Market Share by Application (2024-2029)
Table 68. Global Brucellosis Vaccines Price (USD/K Doses) by Application (2018-2023)
Table 69. Global Brucellosis Vaccines Price (USD/K Doses) by Application (2024-2029)
Table 70. Jinyu Corporation Information
Table 71. Jinyu Description and Business Overview
Table 72. Jinyu Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 73. Jinyu Brucellosis Vaccines Product
Table 74. Jinyu Recent Developments/Updates
Table 75. Colorado Serum Corporation Information
Table 76. Colorado Serum Description and Business Overview
Table 77. Colorado Serum Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 78. Colorado Serum Brucellosis Vaccines Product
Table 79. Colorado Serum Recent Developments/Updates
Table 80. Boehringer Ingelheim Corporation Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 83. Boehringer Ingelheim Brucellosis Vaccines Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Biogenesis-Bago Corporation Information
Table 86. Biogenesis-Bago Description and Business Overview
Table 87. Biogenesis-Bago Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 88. Biogenesis-Bago Brucellosis Vaccines Product
Table 89. Biogenesis-Bago Recent Developments/Updates
Table 90. Vetal Company Corporation Information
Table 91. Vetal Company Description and Business Overview
Table 92. Vetal Company Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 93. Vetal Company Brucellosis Vaccines Product
Table 94. Vetal Company Recent Developments/Updates
Table 95. CZ Veterinaria Corporation Information
Table 96. CZ Veterinaria Description and Business Overview
Table 97. CZ Veterinaria Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 98. CZ Veterinaria Brucellosis Vaccines Product
Table 99. CZ Veterinaria Recent Developments/Updates
Table 100. SYVA Laboratorios Corporation Information
Table 101. SYVA Laboratorios Description and Business Overview
Table 102. SYVA Laboratorios Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 103. SYVA Laboratorios Brucellosis Vaccines Product
Table 104. SYVA Laboratorios Recent Developments/Updates
Table 105. Indian Immunologicals Corporation Information
Table 106. Indian Immunologicals Description and Business Overview
Table 107. Indian Immunologicals Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 108. Indian Immunologicals Brucellosis Vaccines Product
Table 109. Indian Immunologicals Recent Developments/Updates
Table 110. Qilu Corporation Information
Table 111. Qilu Description and Business Overview
Table 112. Qilu Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 113. Qilu Brucellosis Vaccines Product
Table 114. Qilu Recent Developments/Updates
Table 115. Tecnovax Corporation Information
Table 116. Tecnovax Description and Business Overview
Table 117. Tecnovax Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 118. Tecnovax Brucellosis Vaccines Product
Table 119. Tecnovax Recent Developments/Updates
Table 120. Hester Biosciences Corporation Information
Table 121. Hester Biosciences Description and Business Overview
Table 122. Hester Biosciences Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 123. Hester Biosciences Brucellosis Vaccines Product
Table 124. Hester Biosciences Recent Developments/Updates
Table 125. Zoetis Corporation Information
Table 126. Zoetis Description and Business Overview
Table 127. Zoetis Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 128. Zoetis Brucellosis Vaccines Product
Table 129. Zoetis Recent Developments/Updates
Table 130. Onderstepoort Biological Corporation Information
Table 131. Onderstepoort Biological Description and Business Overview
Table 132. Onderstepoort Biological Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 133. Onderstepoort Biological Brucellosis Vaccines Product
Table 134. Onderstepoort Biological Recent Developments/Updates
Table 135. Instituto Rosenbusch Corporation Information
Table 136. Instituto Rosenbusch Description and Business Overview
Table 137. Instituto Rosenbusch Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 138. Instituto Rosenbusch Brucellosis Vaccines Product
Table 139. Instituto Rosenbusch Recent Developments/Updates
Table 140. Ceva Sante Animale Corporation Information
Table 141. Ceva Sante Animale Description and Business Overview
Table 142. Ceva Sante Animale Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 143. Ceva Sante Animale Brucellosis Vaccines Product
Table 144. Ceva Sante Animale Recent Developments/Updates
Table 145. Calier & Biologicos Laverlam Corporation Information
Table 146. Calier & Biologicos Laverlam Description and Business Overview
Table 147. Calier & Biologicos Laverlam Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 148. Calier & Biologicos Laverlam Brucellosis Vaccines Product
Table 149. Calier & Biologicos Laverlam Recent Developments/Updates
Table 150. Biovet Corporation Information
Table 151. Biovet Description and Business Overview
Table 152. Biovet Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 153. Biovet Brucellosis Vaccines Product
Table 154. Biovet Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Brucellosis Vaccines Distributors List
Table 158. Brucellosis Vaccines Customers List
Table 159. Brucellosis Vaccines Market Trends
Table 160. Brucellosis Vaccines Market Drivers
Table 161. Brucellosis Vaccines Market Challenges
Table 162. Brucellosis Vaccines Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Brucellosis Vaccines
Figure 2. Global Brucellosis Vaccines Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Brucellosis Vaccines Market Share by Type in 2022 & 2029
Figure 4. S19 Vaccine Product Picture
Figure 5. RB51 Vaccine Strain Product Picture
Figure 6. Global Brucellosis Vaccines Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Brucellosis Vaccines Market Share by Application in 2022 & 2029
Figure 8. Cattle
Figure 9. Sheep
Figure 10. Others
Figure 11. Global Brucellosis Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Brucellosis Vaccines Market Size (2018-2029) & (US$ Million)
Figure 13. Global Brucellosis Vaccines Sales (2018-2029) & (M Doses)
Figure 14. Global Brucellosis Vaccines Average Price (USD/K Doses) & (2018-2029)
Figure 15. Brucellosis Vaccines Report Years Considered
Figure 16. Brucellosis Vaccines Sales Share by Manufacturers in 2022
Figure 17. Global Brucellosis Vaccines Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Brucellosis Vaccines Players: Market Share by Revenue in 2022
Figure 19. Brucellosis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Brucellosis Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Brucellosis Vaccines Sales Market Share by Country (2018-2029)
Figure 22. North America Brucellosis Vaccines Revenue Market Share by Country (2018-2029)
Figure 23. U.S. Brucellosis Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Brucellosis Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Brucellosis Vaccines Sales Market Share by Country (2018-2029)
Figure 26. Europe Brucellosis Vaccines Revenue Market Share by Country (2018-2029)
Figure 27. Germany Brucellosis Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Brucellosis Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Brucellosis Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Brucellosis Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Brucellosis Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Brucellosis Vaccines Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Brucellosis Vaccines Revenue Market Share by Region (2018-2029)
Figure 34. China Brucellosis Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Brucellosis Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Brucellosis Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Brucellosis Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Brucellosis Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Brucellosis Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Brucellosis Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Brucellosis Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Brucellosis Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Brucellosis Vaccines Sales Market Share by Country (2018-2029)
Figure 44. Latin America Brucellosis Vaccines Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Brucellosis Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Brucellosis Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Brucellosis Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Brucellosis Vaccines Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Brucellosis Vaccines Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Brucellosis Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Brucellosis Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Brucellosis Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Brucellosis Vaccines by Type (2018-2029)
Figure 54. Global Revenue Market Share of Brucellosis Vaccines by Type (2018-2029)
Figure 55. Global Brucellosis Vaccines Price (USD/K Doses) by Type (2018-2029)
Figure 56. Global Sales Market Share of Brucellosis Vaccines by Application (2018-2029)
Figure 57. Global Revenue Market Share of Brucellosis Vaccines by Application (2018-2029)
Figure 58. Global Brucellosis Vaccines Price (USD/K Doses) by Application (2018-2029)
Figure 59. Brucellosis Vaccines Value Chain
Figure 60. Brucellosis Vaccines Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs